Gene therapy strategies for asthma

Gene Therapy

Volumn 4, Issue 6, 1997, Pages 507-516

  Demoly, P ^a   Mathieu, M ^a   Curiel, D T ^b   Godard, Ph ^a   Bousquet, J ^a   Michel, F B ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adhesion molecules; Asthma; Bronchial epithelium; Cytokines; Gene therapy; Inflammation; Lymphocytes

Indexed keywords

CHLOROQUINE; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; DAPSONE; METHOTREXATE; STEROID; TRANSCRIPTION FACTOR; TROLEANDOMYCIN;

ANIMAL MODEL; ASTHMA; CATARACT; CELL INFILTRATION; DIABETES MELLITUS; EOSINOPHIL; GENE THERAPY; GENE TRANSFER; GROWTH DISORDER; HUMAN; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INFECTION; INHALATIONAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; SKIN DEFECT; STEROID THERAPY; T LYMPHOCYTE;

ANIMALIA;

EID: 0030804780     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300419     Document Type: Review

References (95)

1. Burr ML, Butland BK, King S, Vaughan WE. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989; 64: 1452-1456.
2. Woolcock AJ. Worldwide differences in asthma prevalence and mortality. Chest 1986; 90: S40-S45.
3. Bousquet J, Hatton F, Godard Ph, Michel FB. Asthma mortality in France. J Allerg Clin Immunol 1987; 80: 389-394.
4. Arrighi HM. US asthma mortality: 1941 to 1989. Ann Allergy 1995; 74: 321-325.
5. Jackson R, Sear MR, Beaglehole R, Rea HH. International trends in asthma mortality 1970 to 1985. Chest 1988; 94: 914-919.
6. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. New Engl J Med 1992; 326: 862-866.
7. Cooke RA, Van der Veer A. Human sensitization. J Immunol 1916; 1: 201-305.
8. Marsh DG, Meyers DA, Bias WB. The epidemiology and genetics of atopic allergy. New Engl J Med 1981; 305: 1551-1559.
9. Moffatt MF et al. Genetic linkage of T cell receptor alpha/delta complex to specific IgE responses. Lancet 1994; 343: 1597-1600.
10. Marsh DG et al. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations Science 1994; 264: 1152-1156.
11. Cookson WOCM, Sharp PA, Faux JA, Hopkin JM. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989; i: 1292-1295.
12. Turki J et al. Genetic polymorphisms of the beta(2)-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95: 1635-1641.
13. Rosenwasser L et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 5: S74-S78.
14. Gough J. Post-mortem differences in 'asthma' and chronic bronchitis. Acta Allergol 1961; 16: 391-399.
15. Djukanovic R et al. State of the art: mucosal inflammation in asthma. Am Rev Resp Dis 1990, 142: 434-457.
16. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991; 87: 893-910.
17. Paradis L et al. Heterogeneity of glucocorticosteroid (GCs) dependent asthmatics. Am J Resp Crit Care Med 1995; 151: A675.
18. Barnes PJ, Greening AP, Crompton GK. Glucocorticoid resistance in asthma. Am J Resp Crit Care Med 1995; 152: S125-S142.
19. Moss RB Alternative pharmacotherapies for steroid-dependent asthma. Chest 1995; 107: 817-825.
20. Wilkinson JR, Lane SJ, Lee TH. Effects of corticosteroids on cytokine generation and expression of activation antigens by monocytes in bronchial asthma. Int Arch Allergy Appl Immunol 1991; 94: 220-221.
21. Carmichael J et al. Corticosteroid resistance in chronic asthma. Br Med J 1982; 282: 1419-1422.
22. Corrigan CJ et al. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Resp Dis 1991; 144: 1026-1032.
23. Alvarez J et al. Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol 1992; 89: 714-721.
24. Kam JC et al. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993; 151: 3460-3466.
25. Sher E et al. Steroid resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994; 93: 33-39.
26. Adcock IA et al. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 1995; 154: 3500-3505.
27. Adcock IA et al. Abnormal glucocorticoid receptor/AP1 interaction in steroid-resistant asthma. J Exp Med 1995; 182: 1951-1958.
28. Leung DYM et al. Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma. J Exp Med 1995; 181: 33-40.
29. Lane SJ, Arm JP, Staynov DZ, Lee TH. Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma. Am J Resp Cell Mol Biol 1994; 11: 42-48.
30. Rosenfeld MA, Collins FS. Gene therapy for cystic fibrosis. Chest 1996; 109: 241-252.
31. Karol MH. Animal models of occupational asthma. Eur Respir J 1994; 7: 555-568.
32. Lack G et al. Nebulized but not parenteral IFN-γ decreases IgE production and normalizes airway function in a murine model of allergen sensitization. J Immunol 1994; 152: 2546-2554.
33. Kung TT et al. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL5 antibody. Am J Resp Cell Mol Biol 1995; 13: 360-365.
34. Blyth DI et al. Lung inflammation and epithelial changes in a murine model of atopic asthma. Am J Resp Cell Mol Biol 1996; 14: 425-438.
35. - T lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Resp Dis 1992; 146: 374-377.
36. Garlisi CG et al. T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin Immunol Immunopathol 1995; 75: 75-83.
37. Coyle AJ et al. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Resp Cell Mol Biol 1995; 13: 54-59.
38. Kung TT et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Resp Cell Mol Biol 1995; 12: 404-409.
39. Wegner CD et al. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990; 24: 456-459.
40. Gundel RH, Wegner CD, Torcellim CA, Letts LG. The role of intercellular adhesion molecule-1 in chronic airway inflammation. Clin Exp Allergy 1992; 22: 569-575.
41. Miller N, Vile R. Targeted vectors for gene therapy. FASEB J 1995; 9: 190-199.
42. Vos JMH (ed). Viruses in Human Gene Therapy. Academic Press: Durham, NC, 1995
43. Curiel DT, Pilewski JM, Albelda SM. Gene therapy approaches for inherited and acquired lung diseases. Am J Resp Cell Mol Biol 1996; 14: 1-18.
44. Bousquet J et al. Eosinophilic inflammation in asthma. New Engl J Med 1990; 323: 1033-1039.
45. Metzger WJ et al. Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest 1986; 89: 477-483.
46. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Resp Cell Mol Biol 1993; 8: 349-355.
47. Lukacs NW, Strieter RM, Kunkel SL. Leukocyte infiltration in allergic airway inflammation. Am J Resp Cell Mol Biol 1995; 13: 1-6.
48. Woolley KL et al. Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma. Eur Respir J 1994; 7: 1576-1584.
49. Hamid Q et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87: 1541-1546.
50. + T cells, increased Th2-type cytokine mRNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993; 92: 313-324.
51. Das AM, Williams TJ, Lobb R, Nourshargh S. Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model. Immunology 1995; 84: 41-46.
52. Laberge S, Rabb H, Issekutz TB, Martin JG. Role of VLA-4 and LFA-1 in allergen-induced airway hyperresponsiveness and lung inflammation in the rat. Am J Resp Crit Care Med 1995; 151: 822-829.
53. Abraham WM et al. α-4-Integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest 1994; 93. 776-787
54. Mauser PJ et al. Effects of an antibody to IL-5 in a monkey model of asthma. Am J Resp Crit Care Med 1995, 152: 467-172
55. Brusselle G, Kips J, Bluethmann H, Pauwels R. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am J Resp Cell Mol Biol 1995; 12: 254-259.
56. Ohkawara Y et al. In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with airflow limitation: in vivo evidence of VCAM-1/VLA-4 interaction in selective eosinophil infiltration. Am J Resp Cell Mol Biol 1995; 12: 4-12.
57. Leff AR. inflammatory mediation of airway hyperresponsiveness by peripheral blood granulocytes. The case of eosinophils. Chest 1994; 106: 1202-1208.
58. Georas SN et al. Alteres adhesion molecule expression and endothelial cell activation accompany the recruitment of human granulocytes to the lung after segmental allergen challenge. Am J Resp Cell Mol Biol 1992; 7: 261-269.
59. Takahashi N et al. Soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid of allergic subjects following segmental antigen challenge. Am J Resp Crit Care Med 1994; 150: 704-709.
60. Montefort S et al. Circulating adhesion molecules in asthma. Am J Resp Crit Care Med 1994; 149: 1149-1152.
61. Montefort S et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 h after local antigen challenge of sensitized asthmatic airways J Clin Invest 1994; 93: 1411-1421.
62. Sun J et al. Contribution of intercellular adhesion molecule-1 in allergen-induced airway hyperresponsiveness and inflammation in sensitized Brown-Norway rats. Int Arch Allergy Immunol 1994; 104: 291-295.
63. Rabb H et al. The role of the leukocyte adhesion molecules VLA-4, LFA-1, and Mac-1 in allergic airway responses in the rat. Am J Resp Crit Care Med 1994; 149: 1186-1191.
64. Pilewski JM, Abelda SM. Cell adhesion molecules in asthma: homing, activation and airway remodeling. Am J Resp Cell Mol Biol 1995; 12: 1-3.
65. Watson ML et al Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway reactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am J Resp Cell Mol Biol 1994; 8: 365-369.
66. Lefort J et al. In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs. J Clin Invest 1996; 97: 1117-1121.
67. 2. J Clin Invest 1993; 91: 2118-2125.
68. Smith WL. Prostanoid biosynthesis and mechanisms of action. Am I Physiol 1992; 263: F181-F191.
69. Geha RS. Regulation of IgE synthesis in humans. J Allergy Clin Immunol 1992; 90: 143-150
70. Maliszewski CR, Fanslow WC. Soluble receptors for IL-1 and IL-4: biological activity and therapeutic potential. Trends Biotech 1990; 8: 324-329.
71. Aversa G et al. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 1993; 178: 2213-2218.
72. Boguniewicz M et al. Recombinant IFN-γ in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med 1990; 88. 365-370
73. Li JTC et al Lack of suppression of IgE production by recombinant IFN-γ. A controlled trial in patients with allergic rhinitis. J Allergy Clin Immunol 1990; 85: 934-940.
74. Reinhold U, Wehrmann W, Kukel S, Kreysel HW. Recombinant Interferon-γ in severe atopic dermatitis. Lancet 1990; 335: 1282.
75. Boguniewicz M et al. Treatment of steroid-dependent asthma with recombinant interferon-gamma (rIFN-γ). J Allergy Clin Immunol 1992; 89: A288.
76. Jaffe HA et al. Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant IFN-γ to the human lung. J Clin Invest 1991; 88: 297-302.
77. Boguniewicz M et al. Aerosolized recombinant interferon-gamma (rIFN-γ) in normal subjects and asthmatics. J Allergy Clin Immunol 1993; 91: A226.
78. Fanslow WCDM et al. Soluble forms of CD40 inhibit biologic responses of human B cells. J Immunol 1992; 149: 655-660.
79. Lustgarten J, Eshhar Z. Specific elimination of IgE production using T cell lines expressing chimeric T cell receptor genes. Eur J Immunol 1995; 25: 2985-2991.
80. Bousquet J, Michel FB. Specific immunotherapy in asthma is it effective? J Allergy Clin Immunol 1994; 94: 1-11.
81. McDonnel WM, Askari FK. DNA vaccines. New Engl J Med 1996; 334: 42-45.
82. Raz E et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996; 93: 5141-5145.
83. Hsu CH et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nature Med 1996; 2: 540-544.
84. Mullarkey MF et al. Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor. J Immunol 1994; 152: 2033-2041.
85. Haak-Frendscho M et al. Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody. J Immunol 1994; 152: 1347-1351.
86. Manetti R et al. Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993; 177: 1199-1204.
87. Sur S et al. IL-12 decreases allergen induced eosinophil recruitment and Th2 cytokine mRNA expression in BAL cells. Allergy 1996; 51: 23.
88. Howard M et al. Biological properties of interleukin 10. J Clin Immunol 1992; 12: 239-247.
89. Bonfield TL et al. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Resp Cell Mol Biol 1995; 13: 257-261.
90. Punnonen J, de Waal Malefyt R. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 1993; 151: 1280-1289.
91. Takanashi S et al. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994; 180: 711-715.
92. Wooley MJ et al. Inhibitory effects of IL-10 on allergen-induced airway inflammation and airway responses in Brown Norway rats. Am J Resp Crit Care Med 1994; 148: A760.
93. Ohkawara Y, Xing Z, Gauldie J, Jordana M. Adenovirus vector-mediated gene transfer of murine interleukin-10 (mIL-10) inhibits antigen induced airways inflammation in sensitized mice. Am J Resp Crit Care Med 1996; 152: A143.
94. Gronemeyer H. Control of transcription activation by steroid hormone receptors. FASEB J 1992; 6: 2524-2529.
95. Wrighton CJ et al. Inhibition of endothelial cell activation by adenovirus-mediated expression of IκBα, an inhibitor of the transcription factor NF-κB. J Exp Med 1996; 183: 1013-1022.